Joseph
July 21st, 2009, 11:55
This is only going to get burried like the Wawer study, but here goes anyway...
http://www.journals.uchicago.edu/doi/abs/10.1086/600074
The Journal of Infectious Diseases 2009;200:370–378
© 2009 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/2009/20003-0008$15.00
DOI: 10.1086/600074
MAJOR ARTICLE
Adult Male Circumcision Does Not Reduce the Risk of Incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis Infection: Results from a Randomized, Controlled Trial in Kenya
Supriya D. Mehta,1
Stephen Moses,3,4,5
Kawango Agot,6
Corette Parker,2
Jeckoniah O. Ndinya‐Achola,7
Ian Maclean,3 and
Robert C. Bailey1
1Department of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, Illinois; 2RTI International, Research Triangle Park, North Carolina; Departments of 3Medical Microbiology, 4Community Health Sciences, and 5Internal Medicine University of Manitoba, Winnipeg, Canada; and 6University of Nairobi, Illinois, and Manitoba Project, Kisumu, and 7Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
Background.We examined the effect of male circumcision on the acquisition of 3 nonulcerative sexually transmitted infections (STIs).
Methods.We evaluated the incidence of STI among men aged 18–24 years enrolled in a randomized trial of circumcision to prevent human immunodeficiency virus (HIV) infection in Kisumu, Kenya. The outcome was first incident nonulcerative STI during 2 years of follow‐up. STIs examined were laboratory‐detected Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infection.
Results.There were 342 incident infections among 2655 men followed up. The incidences of infection due to N. gonorrhoeae, C. trachomatis, and T. vaginalis were 3.48, 4.55, and 1.32 cases per 100 person‐years, respectively. The combined incidence of N. gonorrhoeae and C. trachomatis infection was 7.26 cases per 100 person‐years (95% confidence interval, 6.49–8.13 cases per 100 person‐years). The incidences of these STIs, individually or combined, did not differ by circumcision status as a time‐dependent variable or a fixed variable based on assignment. Risks for incident STIs in multivariate analysis included an STI at enrollment, multiple sex partners within <30 days, and sexual intercourse during menses in the previous 6 months; condom use was protective.
Conclusions.Circumcision of men in this population did not reduce their risk of acquiring these nonulcerative STIs. Improved STI control will require more‐effective STI management, including partner treatment and behavioral risk reduction counseling.
Received 16 December 2008; accepted 27 February 2009; electronically published 19 June 2009.
Reprints or correspondence: Dr. Mehta, 1603 W. Taylor St., M/C 923, Chicago, IL 60622 (supriyad@uic.edu).
Potential conflicts of interest: none reported.
Financial support: Family Health International, supported by the US Government and the Bill and Melinda Gates Foundation (to R.C.B.); Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (AI50440); and Canadian Institutes of Health Research (HCT 44180; investigator award to S.M.).
http://www.journals.uchicago.edu/doi/abs/10.1086/600074
The Journal of Infectious Diseases 2009;200:370–378
© 2009 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/2009/20003-0008$15.00
DOI: 10.1086/600074
MAJOR ARTICLE
Adult Male Circumcision Does Not Reduce the Risk of Incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis Infection: Results from a Randomized, Controlled Trial in Kenya
Supriya D. Mehta,1
Stephen Moses,3,4,5
Kawango Agot,6
Corette Parker,2
Jeckoniah O. Ndinya‐Achola,7
Ian Maclean,3 and
Robert C. Bailey1
1Department of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, Illinois; 2RTI International, Research Triangle Park, North Carolina; Departments of 3Medical Microbiology, 4Community Health Sciences, and 5Internal Medicine University of Manitoba, Winnipeg, Canada; and 6University of Nairobi, Illinois, and Manitoba Project, Kisumu, and 7Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya
Background.We examined the effect of male circumcision on the acquisition of 3 nonulcerative sexually transmitted infections (STIs).
Methods.We evaluated the incidence of STI among men aged 18–24 years enrolled in a randomized trial of circumcision to prevent human immunodeficiency virus (HIV) infection in Kisumu, Kenya. The outcome was first incident nonulcerative STI during 2 years of follow‐up. STIs examined were laboratory‐detected Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infection.
Results.There were 342 incident infections among 2655 men followed up. The incidences of infection due to N. gonorrhoeae, C. trachomatis, and T. vaginalis were 3.48, 4.55, and 1.32 cases per 100 person‐years, respectively. The combined incidence of N. gonorrhoeae and C. trachomatis infection was 7.26 cases per 100 person‐years (95% confidence interval, 6.49–8.13 cases per 100 person‐years). The incidences of these STIs, individually or combined, did not differ by circumcision status as a time‐dependent variable or a fixed variable based on assignment. Risks for incident STIs in multivariate analysis included an STI at enrollment, multiple sex partners within <30 days, and sexual intercourse during menses in the previous 6 months; condom use was protective.
Conclusions.Circumcision of men in this population did not reduce their risk of acquiring these nonulcerative STIs. Improved STI control will require more‐effective STI management, including partner treatment and behavioral risk reduction counseling.
Received 16 December 2008; accepted 27 February 2009; electronically published 19 June 2009.
Reprints or correspondence: Dr. Mehta, 1603 W. Taylor St., M/C 923, Chicago, IL 60622 (supriyad@uic.edu).
Potential conflicts of interest: none reported.
Financial support: Family Health International, supported by the US Government and the Bill and Melinda Gates Foundation (to R.C.B.); Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (AI50440); and Canadian Institutes of Health Research (HCT 44180; investigator award to S.M.).